Laurus Labs
Search results
Ipca Laboratories is a leading pharmaceutical company across the continents that work on its core values of quality, safety, integrity, dignity, responsibility. Ipca is a fully-integrated Indian pharmaceutical company manufacturing over 350 formulations and 80 APIs for various therapeutic segments.
Ipca Laboratories Limited is an Indian multinational pharmaceutical company based in Mumbai. It produces theobromine, acetylthiophene, and p-bromotoluene as active pharmaceutical ingredients (APIs). Ipca sells these APIs and their intermediates globally.
Ipca Laboratories is the largest pharmaceutical Company known for manufacturing and exporting over 350 formulations and 80 APIs globally since 1949.
1 day ago · Ipca Laboratories Ltd is a fully-integrated Indian pharmaceutical company manufacturing over 350 formulations and 80 APIs for various therapeutic segments. It is one of the world`s largest ...
Ipca Laboratories is the leading API formulations manufacture & export with a reliable supply chain in over 120 countries. Contact us for more information.
Ipca Laboratories Limited | 310,894 followers on LinkedIn. A consumer-led global pharmaceutical company, creating healthy doses of life since 1949. When you operate in an industry like...
International Business. Products of the company are now exported to over 100 countries across the globe. Recognized Star Trading House. 46% sales from exports.
IPCA Laboratories Limited Stock Price Today, Live NSE Share Price: Get the latest IPCA Laboratories Limited news, company updates, quotes, tips, historical charts, 52 week high low, market performance financial reports and many more at NSE India.
Ipca Laboratories Limited is a Public incorporated on 19 October 1949. It is classified as Non-government company and is registered at Registrar of Companies, ROC Mumbai. Its authorized share capital is Rs. 576,000,000 and its paid up capital is Rs. 253,700,000.
Get Ipca Laboratories Ltd. share price today, stock analysis, stock rating, price valuation, performance, fundamentals, market cap, shareholding, and financial report.
